These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7716950)

  • 21. [Effects of simvastatin on plasma lipoproteins].
    Alessandri C; Basili S; Maurelli M; Andreozzi P; Bracaglia D; Cordova C
    Clin Ter; 1994 Jan; 144(1):3-9. PubMed ID: 8168349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of dyslipidemia of the elderly with simvastatin and pravastatin. Effectiveness and tolerance].
    Panuccio D; Trabatti MR; Romani A
    Clin Ter; 1994 May; 144(5):419-24. PubMed ID: 7924180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of apolipoprotein B in primary moderate hypercholesterolaemia: effects of acipimox and cholestyramine therapy.
    Gaw A; Packard CJ; Lindsay GM; Collins SM; Lorimer AR; Shepherd J
    Eur J Med Res; 1995 Oct; 1(1):38-48. PubMed ID: 9392692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypolipemic drug therapy.
    Tan MH
    CMAJ; 1989 Dec; 141(12):1250. PubMed ID: 2590892
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medical recommendations and references about hypolipidemic drugs. ANDEM (National Agency for the Development of Medical Evaluation].
    J Mal Vasc; 1997 Oct; 22(4):249-64. PubMed ID: 9411011
    [No Abstract]   [Full Text] [Related]  

  • 26. [Goal in hypercholesterolemia: lowering LDL cholesterol level by 50%].
    MMW Fortschr Med; 2005 Jul; 147(27-28):51. PubMed ID: 16041948
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening and treatment recommendations for adults with hypercholesterolemia.
    Ennis ED; Kreisberg RA
    Compr Ther; 1996 Aug; 22(8):492-500. PubMed ID: 8879916
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
    Krempf M; Rohmer V; Farnier M; Issa-Sayegh M; Corda C; Sirugue I; Gerlinger C; Masseyeff-Elbaz MF
    Diabetes Metab; 2000 May; 26(3):184-91. PubMed ID: 10880891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis.
    Schaffner F
    Gastroenterology; 1969 Sep; 57(3):253-5. PubMed ID: 5808484
    [No Abstract]   [Full Text] [Related]  

  • 30. [Controversies and advances in the treatment of hyperlipidemias].
    Reza-Albarrán A; Aguilar-Salinas CA
    Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical effectiveness of acipimox and fenofibrate in patients with hyperlipoproteinemia type II].
    Chojnowska-Jezierska J; Jabłoński S; Tkaczewski W
    Wiad Lek; 1993 May; 46(9-10):332-6. PubMed ID: 8236987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
    Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
    Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the effects of tiadenol in various types of dyslipidemia].
    Saettone G; Cazzani E; Romanò M; Muzio L
    Clin Ter; 1982 May; 101(4):387-93. PubMed ID: 7105643
    [No Abstract]   [Full Text] [Related]  

  • 34. Cholesterol treatment guidelines update.
    Safeer RS; Ugalat PS
    Am Fam Physician; 2002 Mar; 65(5):871-80. PubMed ID: 11898959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group.
    Locker PK; Jungbluth GL; Francom SF; Hughes GS
    Clin Pharmacol Ther; 1995 Jan; 57(1):73-88. PubMed ID: 7828385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ezetimib and simvastatin. Cooperation at receptors of cholesterol metabolism].
    MMW Fortschr Med; 2005 Jul; 147(27-28):50. PubMed ID: 16041947
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hydroxymethylglutaryl coenzyme A reductase inhibitors].
    Schuff-Werner P
    Internist (Berl); 1994 Mar; 35(3):288-94; discussion 295. PubMed ID: 8175295
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
    Ballantyne CM; Davidson MH; McKenney J; Keller LH; Bajorunas DR; Karas RH
    Am J Cardiol; 2008 May; 101(10):1428-36. PubMed ID: 18471454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Indications for decreasing lipid values. Patients with healthy hearts with low HDL clearly profit].
    MMW Fortschr Med; 2000 Nov; 142(48):68. PubMed ID: 11138292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.